Kir2.1

KCNJ2
Identifiers
AliasesKCNJ2, ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7, SQT3, potassium voltage-gated channel subfamily J member 2, potassium inwardly rectifying channel subfamily J member 2
External IDsOMIM: 600681; MGI: 104744; GeneCards: KCNJ2
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000891

NM_008425

RefSeq (protein)

NP_000882

NP_032451

Location (UCSC)Chr 17: 70.17 – 70.18 MbChr 11: 110.96 – 110.97 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

The Kir2.1 inward-rectifier potassium channel is a lipid-gated ion channel encoded by the KCNJ2 gene.

Regulation

Kir2.1 activity is promoted by the phospholipid PIP2.

Clinical significance

A defect in this gene is associated with Andersen-Tawil syndrome.

A mutation in the KCNJ2 gene has also been shown to cause short QT syndrome.

Kir2.1 impairment has been linked to endothelial dysfunction in metabolic disease. This is thought to be due in part to impairment of the channel by fatty acids.

In research

In neurogenetics, Kir2.1 is used in Drosophila research to inhibit neurons, as overexpression of this channel will hyperpolarize cells.

In optogenetics, a trafficking sequence from Kir2.1 has been added to halorhodopsin to improve its membrane localization. The resulting protein eNpHR3.0 is used in optogenetic research to inhibit neurons with light.

Expression of Kir2.1 gene in human HEK293 cells induce a transient outward current, creating a steady membrane potential close to the reversal potential of potassium.

Interactions

Kir2.1 has been shown to interact with: